The whole thing is pretty sad. The head of Elsevier as well as multiple people that have worked at Elsevier seem to have not been aware of that these were being used to pretend they were real journals. But I think one this is abundantly clear - we can cross of the list of criticisms of Open Access publishing that the costly non open access journals and publishers are protecting the world from bad science. Instead, it seems like they are in fact explicitly and purposefully pushing bad science and medicine in order to make extra money. Lovely.
For more informaiton on the story see for example, Kate McDonald in the Australian Life Scientist (see Elsevier published fake medical journals - Elsevier Australia, Merck, Vioxx - Australian Life Scientist). In this article she reports:
The CEO of Elsevier’s Health Sciences division in the US, Michael Hansen, has now issued a statement admitting the company’s Australian office published six journals paid for by pharmaceutical companies.Also see for example Forbes (via AP). The best source on this has been the Bloggosphere where there were a large number of discussions including
- Nature's the Great Beyond
- Science Now,
- Peter Suber
- Janet Stemwedel from SciencBlogs
- Chris Patil at Ouroboros
- Laika's Media Blog
There also has been some other discussion on FriendFeed including the following from a Graham Steel posting:
thank you! That looks like a great resource.
ReplyDeleteI like having opportunities to use the word Schadenfreude in the correct context! That's what I feel when I read about Elsevier squirming to try to explain their behavior. Six fake journals! And now I have to wonder if that's all there are, and if other publishers have done anything similar. After all, it appears this was Merck's idea, so why wouldn't they and other companies approach other publishers?
ReplyDeleteI blogged about this too: http://genome.fieldofscience.com/2009/05/merck-paid-elsevier-to-create-fake.html
My friend Saul J will be very happy you used Schadenfreude here ... his favorite work.
ReplyDelete